Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
BMC Health Serv Res ; 10: 269, 2010 Sep 10.
Article in English | MEDLINE | ID: mdl-20831805

ABSTRACT

BACKGROUND: Utilization of specialty care may not be a discrete, isolated behavior but rather, a behavior of sequential movements within the health care system. Although patients may often visit their primary care physician and receive a referral before utilizing specialty care, prior studies have underestimated the importance of accounting for these sequential movements. METHODS: The sample included 6,772 adults aged 18 years and older who participated in the 2001 Survey on Disparities in Quality of Care, sponsored by the Commonwealth Fund. A sequential logit model was used to account for movement in all stages of utilization: use of any health services (i.e., first stage), having a perceived need for specialty care (i.e., second stage), and utilization of specialty care (i.e., third stage). In the sequential logit model, all stages are nested within the previous stage. RESULTS: Gender, race/ethnicity, education and poor health had significant explanatory effects with regard to use of any health services and having a perceived need for specialty care, however racial/ethnic, gender, and educational disparities were not present in utilization of specialty care. After controlling for use of any health services and having a perceived need for specialty care, inability to pay for specialty care via income (AOR = 1.334, CI = 1.10 to 1.62) or health insurance (unstable insurance: AOR = 0.26, CI = 0.14 to 0.48; no insurance: AOR = 0.12, CI = 0.07 to 0.20) were significant barriers to utilization of specialty care. CONCLUSIONS: Use of a sequential logit model to examine utilization of specialty care resulted in a detailed representation of utilization behaviors and patient characteristics that impact these behaviors at all stages within the health care system. After controlling for sequential movements within the health care system, the biggest barrier to utilizing specialty care is the inability to pay, while racial, gender, and educational disparities diminish to non-significance. Findings from this study represent how Americans use the health care system and more precisely reveals the disparities and inequalities in the U.S. health care system.


Subject(s)
Delivery of Health Care/statistics & numerical data , Health Services Needs and Demand , Health Services/statistics & numerical data , Healthcare Disparities/statistics & numerical data , Models, Statistical , Referral and Consultation/statistics & numerical data , Adult , Aged , Ethnicity/statistics & numerical data , Female , Health Care Surveys , Health Services Accessibility/statistics & numerical data , Humans , Logistic Models , Male , Middle Aged , Physicians, Primary Care/statistics & numerical data , Referral and Consultation/trends , Risk Assessment , Socioeconomic Factors , Surveys and Questionnaires , United States , Young Adult
2.
Cancer Res ; 67(20): 9616-22, 2007 Oct 15.
Article in English | MEDLINE | ID: mdl-17942889

ABSTRACT

Using an expression cloning approach, we identify CUL7, a member of the cullin family, as a functional inhibitor of Myc-induced apoptosis. Deregulated expression of the Myc oncogene drives cellular proliferation yet also sensitizes cells to undergo p53-dependent and p53-independent apoptosis. Here, we report that CUL7 exerts its antiapoptotic function through p53. CUL7 binds directly to p53, and small interfering RNA-mediated knockdown of CUL7 results in the elevation of p53 protein levels. This antiapoptotic role of CUL7 enables this novel oncogene to cooperate with Myc to drive transformation. Deregulated ectopic expression of c-Myc and CUL7 promotes Rat1a cell growth in soft agar, and knockdown of CUL7 significantly blocks human neuroblastoma SHEP cell growth in an anchorage-independent manner. Furthermore, using public microarray data sets, we show that CUL7 mRNA is significantly overexpressed in non-small cell lung carcinoma and is associated with poor patient prognosis. We provide experimental evidence to show CUL7 is a new oncogene that cooperates with Myc in transformation by blocking Myc-induced apoptosis in a p53-dependent manner.


Subject(s)
Apoptosis/genetics , Cullin Proteins/genetics , Oncogenes , Animals , Bone Neoplasms/genetics , Bone Neoplasms/metabolism , Bone Neoplasms/pathology , Cell Growth Processes/genetics , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Cullin Proteins/metabolism , Humans , Osteosarcoma/genetics , Osteosarcoma/metabolism , Osteosarcoma/pathology , Proto-Oncogene Proteins c-myc/genetics , RNA, Small Interfering/genetics , Rats , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
3.
Am J Public Health ; 97(2): 259-66, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17194865

ABSTRACT

OBJECTIVES: We examined the effects of maternal and provider characteristics on the up-to-date immunization status of children. METHODS: We used data from the 2003 National Immunization Survey to determine variations in children's up-to-date status in the 4:3:1:3 immunization series. RESULTS: Low maternal educational levels and low socioeconomic status were associated with high 4:3:1:3 series completion rates. Also, completion rates were high in Hispanic and non-Hispanic Black families with low income-to-poverty ratios. CONCLUSIONS: We found that children of less educated mothers and children in Hispanic and non-Hispanic Black families with low income-to-poverty ratios were more likely to have completed the 4:3:1:3 series. Although the reasons for these results need further exploration in other data sets, possible factors are Hispanics' positive cultural attitudes regarding the needs and importance of young children and provision of information on immunizations to low-income minority mothers who access government-subsidized health care programs.


Subject(s)
Child Health Services/statistics & numerical data , Health Care Surveys , Immunization Programs/statistics & numerical data , Minority Groups/psychology , Mothers/psychology , Patient Acceptance of Health Care/ethnology , Vaccination/statistics & numerical data , Adult , Black or African American , Child, Preschool , Female , Hispanic or Latino , Humans , Infant , Kaplan-Meier Estimate , Minority Groups/education , Mother-Child Relations/ethnology , Mothers/education , Patient Acceptance of Health Care/statistics & numerical data , Poverty , Proportional Hazards Models , Social Class , United States , White People
4.
PLoS One ; 9(12): e115337, 2014.
Article in English | MEDLINE | ID: mdl-25522242

ABSTRACT

The c-MYC transcription factor is a master regulator of many cellular processes and deregulation of this oncogene has been linked to more than 50% of all cancers. This deregulation can take many forms, including altered post-translational regulation. Here, using immunoprecipitation combined with mass spectrometry, we identified a MYC SUMOylation site (K326). Abrogation of signaling through this residue by substitution with arginine (K326R) has no obvious effects on MYC half-life, intracellular localization, transcriptional targets, nor on the biological effects of MYC overexpression in two different cell systems assessed for soft agar colony formation, proliferation, and apoptosis. While we have definitively demonstrated that MYC SUMOylation can occur on K326, future work will be needed to elucidate the mechanisms and biological significance of MYC regulation by SUMOylation.


Subject(s)
Proto-Oncogene Proteins c-myc/metabolism , Sumoylation , Amino Acid Substitution , Arginine/genetics , Arginine/metabolism , HEK293 Cells , Humans , MCF-7 Cells , Mass Spectrometry , Proto-Oncogene Proteins c-myc/genetics
5.
Ann Thorac Surg ; 92(3): 998-1005; discussion 1005-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21871290

ABSTRACT

BACKGROUND: More than 11 million Americans live with chronic lung disease; in search for an alternative to donor organs, we attempted to regenerate lungs based on perfusion decellularized lung scaffolds that can be transplanted similar to a donor organ. METHODS: Cadaveric rat lungs were decellularized by detergent perfusion. Resulting scaffolds were mounted in bioreactors and seeded with endothelial and fetal lung cells. Biomimetic organ culture was maintained for 7 days. Resulting bioartificial left lungs were transplanted in orthotopic position after left pneumonectomy in rats. Cadaveric left lung transplants and pneumonectomies served as controls. Blood gas analyses, compliance testing, and fluoroscopies were performed on postoperative days 1, 7, and 14. Lungs were removed for final analysis on day 14. RESULTS: Perfusion decellularization of cadaveric lungs yielded acellular scaffolds with intact architecture and matrix composition. Alveolar volumes, number, and size were comparable in bioartificial and native lungs, as were gas exchange, vital capacity and compliance in vitro. After using improved graft preservation and postoperative weaning protocols, animals could be fully recovered, and bioartificial lung constructs provided oxygenation as long as 7 days at levels comparable to cadaveric lung transplants. Compliance, gas exchange, and radiographic appearance gradually declined over the subsequent 7 days owing to progressive graft consolidation and inflammation. CONCLUSIONS: Perfusion decellularization of cadaveric lungs yields intact scaffolds that can be seeded with cells to generate bioartificial lung grafts. After orthotopic transplantation, grafts are perfused by the recipient's circulation, ventilated through the recipient's airway and provide gas exchange in vivo for 7 days.


Subject(s)
Bioartificial Organs , Lung Diseases/surgery , Lung Transplantation/physiology , Lung/physiology , Oxygen Consumption/physiology , Animals , Blood Gas Analysis , Chronic Disease , Disease Models, Animal , Lung Compliance/physiology , Lung Diseases/physiopathology , Male , Organ Culture Techniques , Organ Preservation/methods , Perfusion/methods , Rats , Rats, Nude , Rats, Sprague-Dawley
6.
Pediatrics ; 120(4): e1043-50, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17908724

ABSTRACT

OBJECTIVES: This study presents a geographical comparison of state-specific prevalence estimates of children who are at risk of overweight and/or overweight using the 2003 National Survey of Children's Health. METHODS: Using the 2003 National Survey of Children's Health, we computed prevalence estimates of children who are at risk of overweight and/or overweight among a nationally representative sample of 69,000 children between 5 and 17 years old. RESULTS: Overall, 36.4% of the children (39.8% of the boys and 32% of the girls) in the sample were in the combined category of at risk of overweight or overweight, representing an estimated 17 million US children. We found geographic variation at the state and the regional levels. The southeastern states, especially those west of the Appalachians and in the lower Mississippi region, had the highest prevalence of children who are at risk of overweight and/or overweight. The central Rocky Mountain states of Colorado, Utah, and Wyoming had the lowest prevalence, followed by the northwestern quadrant of the lower 48 states and New England. CONCLUSIONS: These National Survey of Children's Health data provide clinicians and public health professionals with useful data required for policy and planning related to childhood obesity at state levels. These data also serve as important baseline indicators and can be used to track changes over time.


Subject(s)
Overweight , Population Surveillance , Adolescent , Body Mass Index , Child , Child, Preschool , Female , Health Surveys , Humans , Male , Prevalence , Racial Groups/statistics & numerical data , Risk , Sex Distribution , United States/epidemiology
8.
Semin Cancer Biol ; 16(4): 275-87, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16945552

ABSTRACT

The discovery that the Myc oncoprotein could drive cells to undergo apoptosis in addition to its well-established role in cellular proliferation came in the early 1990s, at the beginning of a period of explosive research on cell death. Experimental evidence revealed that Myc sensitises cells to a wide range of death stimuli and abrogating this biological activity plays a profound role in tumorigenesis. Our understanding of the molecular mechanism and genetic programme of Myc-induced apoptosis remains shrouded in mystery and the focus of much attention. In this review, we will discuss established data, recent advances and future objectives regarding the regulatory processes and the functional cooperators that effect and abrogate apoptosis induced by Myc.


Subject(s)
Apoptosis , Proto-Oncogene Proteins c-myc/physiology , Signal Transduction , Humans
SELECTION OF CITATIONS
SEARCH DETAIL